Impact of T-cell Engagers on COVID-19-related Mortality in B-cell Lymphoma Patients Receiving B-cell Depleting Therapy

CONCLUSION: B-cell lymphoma patients treated with TCE had significantly worse outcomes from COVID-19 than those treated with RTX. TCE therapy should be used with caution in B-cell lymphoma patients during the COVID-19 epidemic.PMID:37448122 | DOI:10.4143/crt.2023.738

Source: Cell Research - July 14, 2023 Category: Cytology Authors: Chan Mi Lee Pyoeng Gyun Choe Chang Kyung Kang Hyeon Jae Jo Nam Joong Kim Sung-Soo Yoon Tae Min Kim Wan Beom Park Myoung-Don Oh Source Type: research